KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,552,811 | +106397.6% | 504,193 | -8.7% | 0.23% | -0.4% |
| Q3 2022 | $7,092 | +74.3% | 552,350 | +31.5% | 0.23% | +66.9% |
| Q2 2022 | $4,070 | -44.8% | 419,995 | -43.4% | 0.14% | -24.0% |
| Q1 2022 | $7,377 | +4.5% | 742,158 | +23.8% | 0.18% | +26.2% |
| Q4 2021 | $7,056 | +52.7% | 599,522 | +47.7% | 0.14% | +64.8% |
| Q3 2021 | $4,622 | – | 405,834 | – | 0.09% | – |
Download | ||||||